Articles

Find an Article

Filter articles

Applied Filters

Showing 31 to 40 of 302 results

LSIPR 50 2018: Mike Young

US20-08-2018

Mike Young was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

LSIPR 50 2018: Alisa Harbin

Switzerland17-08-2018

Alisa Harbin was selected in the LSIPR 50 2018 publication for​ ​her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.

LSIPR 50 2018: Padmanabh Bhatt

US15-08-2018

Padmanabh Bhatt was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the legal section, as LSIPR reports.

Combination SPCs: shaken and stirred

UK14-08-2018Joel Beevers and Michael Pears

Following a CJEU decision in July, and with two more cases on the horizon, Joel Beevers and Michael Pears of Potter Clarkson report on whether an active ingredient (or combination of active ingredients) is ‘protected by a basic patent’, as required for a supplementary protection certificate.

LSIPR 50 2018: Richard Gonzalez

US07-08-2018

Richard Gonzalez was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

Event preview: BioPharm America 2018

US06-08-2018Kari Luu

BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports.

LSIPR 50 2018: Bernard Tyson

US25-07-2018

Bernard Tyson was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.

LSIPR 50 2018: Raymond Chen and Kathleen O’Malley

US20-07-2018

Raymond Chen and Kathleen O’Malley were selected in the LSIPR 50 2018 publication for​ ​their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports.

The future of precision medicine part 2: data is king

International, UK17-07-2018Daniel Lim

In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports.

LSIPR 50 2018: An agent of change in healthcare

US16-07-2018

Healthcare investment yields the best returns when focusing on its core aims and forging strong partnerships, James Flynn, managing partner of Deerfield, tells LSIPR.

Showing 31 to 40 of 302 results

LSIPR